Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/172894
Abnormal expression and distribution of MMP2 at initial stages of Alzheimer's disease-related pathology
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Previous studies have shown that metalloproteinases (MMPs) participate in the clearance of amyloid-β (Aβ) in Alzheimer's disease (AD); MMP2 and MMP3 cleave soluble Aβ, and both MMP9 and MT1-MMP are able to degrade soluble and fibrillar forms of Aβ. The present study shows increased expression levels of active MMP2 in the entorhinal cortex at early stages of AD-related pathology (Braak and Braak stages I/II-0 and III/IV-A) as revealed by western blotting and gelatin zymography. Confocal microscopy discloses co-localization of MMP2 and phospho-tau in neurofibrillary tangles and dystrophic neurites. MMP2 has the capacity to cleave recombinant tau in vitro in a dose-dependent manner, consistent with a physiological function of MMP2 in normal tau proteolysis. However, MMP2 does not cleave hyperphosphorylated and dephosphorylated tau from enriched paired helical filament fractions. These observations raise the possibility that accumulation of MMP2 in neurofibrillary tangles and concomitant loss of proteolytic capacity on tau protein is a response geared to eliminating production of toxic truncated tau species in AD brains. Keywords: Alzheimer's disease, metalloproteinases, MMP2, neurofibrillary tangles, tau
Matèries (anglès)
Citació
Citació
TERNI, Beatrice, FERRER, Isidro (ferrer abizanda). Abnormal expression and distribution of MMP2 at initial stages of Alzheimer's disease-related pathology. _Journal of Alzheimer's Disease_. 2015. Vol. 46, núm. 2, pàgs. 461-469. [consulta: 24 de gener de 2026]. ISSN: 1387-2877. [Disponible a: https://hdl.handle.net/2445/172894]